Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Benzocaine 2% / Chloroxylenol 0.106% oromucosal gel SF
1203010C0AAALAL
|
Benzocaine (Systemic) | Benzocaine | Ear, Nose and Oropharynx | No data available |
|
Benzocaine 2% / Mepyramine 2% spray
1303000B0AAAKAK
|
Benzocaine (Topical) | Benzocaine | Skin | No data available |
|
Boots Anaesthetic and Antibiotic throat lozenges
1203030B0BFAAAC
|
Boots antiseptic (Benzocaine) | Benzocaine | Ear, Nose and Oropharynx | No data available |
|
BurnEze 1% spray
1303000B0BDAAAI
|
BurnEze | Benzocaine | Skin | No data available |
|
Children's Chloraseptic 0.71% Sore Throat spray
1203030B0BRAAAI
|
Children's Chloraseptic | Benzocaine | Ear, Nose and Oropharynx | No data available |
|
Dequacaine lozenges
1203030B0BLAAAE
|
Dequacaine | Benzocaine | Ear, Nose and Oropharynx | No data available |
|
Lanacane 3% cream
1303000B0BCAAAF
|
Lanacane | Benzocaine | Skin | No data available |
|
Merocaine lozenges
1203030B0BNAAAH
|
Merocaine | Benzocaine | Ear, Nose and Oropharynx | No data available |
|
Rinstead Adult gel
1203010C0BGAAAL
|
Rinstead (Benzocaine) | Benzocaine | Ear, Nose and Oropharynx | No data available |
|
Solarcaine cream
1303000B0BBAAAB
|
Solarcaine (Benzocaine/triclosan) | Benzocaine | Skin | No data available |
|
Solarcaine lotion
1303000B0BBABAC
|
Solarcaine (Benzocaine/triclosan) | Benzocaine | Skin | No data available |
|
Solarcaine spray
1303000B0BBADAE
|
Solarcaine (Benzocaine/triclosan) | Benzocaine | Skin | No data available |
|
Wasp-Eze spray
1303000B0BEACAJ
|
Wasp-Eze (Spray) | Benzocaine | Skin | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.